Carpal Tunnel Syndrome As a Predictor of Isolated Systemic Primary AL Amyloidosis

Seldin, 2005, Arthritis accompanying systemic diseases, Vol. II., 1697 Sims, 1994, The epidemiology of AL and AA amyloidosis, Bailliere Clin Rheumatol, 8, 627, 10.1016/S0950-3579(05)80119-0 Abraham, 2002, Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma, Clin Chem, 48, 655, 10.1093/clinchem/48.4.655 Elghetany, 1988, Methods for staining amyloid in tissues: a review, Stain Technol, 63, 201, 10.3109/10520298809107185 Arbustini, 1997, Light and electron microscopy immunohistochemical characterization of Amyloid deposits, Amyloid - Int J Exp Clin Invest, 4, 157 Lim, 2001, Identification and localization of a cysteinyl pottranslational modification in an amyloidogenic kappa 1 light chain protein by electrospray ionization and matrixted laser desoption/desonisation mass spectrometry, Anal Biochem, 295, 45, 10.1006/abio.2001.5187 Skinner, 1996, Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only, Am J Med, 100, 290, 10.1016/S0002-9343(97)89487-9 Resnick, 1998 van Gameren, 2002, AL amyloidosis treated with induction chemotherapy with VAD followed by hight dose melphalan and autologous stem cell transplantation, Amyloid: J Protein Folding Disorders, 9, 165, 10.3109/13506120209114818 Pepys, 2002, Targeted pharmalogical depletion of serum amyloid P component for treatment of human amyloidosis, Nature, 417, 254, 10.1038/417254a